BioSpace News Archive

Press Releases

Kyowa Kirin Announces Positive Interim Real-world Data for Mogamulizumab (Poteligeo®) in Cutaneous T-cell Lymphoma at EORTC-CLTG 2024

October 8, 2024
·
9 min read
Press Releases

CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing

October 8, 2024
·
3 min read
Press Releases

EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA

October 8, 2024
·
2 min read
Press Releases

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow

October 8, 2024
·
9 min read
Press Releases

Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test

October 8, 2024
·
3 min read
Press Releases

BPGbio CEO Dr. Niven R. Narain Honored as PharmaVoice 100 Winner for Pioneering Work in AI-Driven Drug Discovery

October 8, 2024
·
4 min read
Press Releases

Vividion Therapeutics Appoints Frank Poschen to Board of Directors

October 8, 2024
·
3 min read
Press Releases

POLARIS Laboratories Announces Strategic Investment from Riverspan Partners to Accelerate Innovation and Growth

October 8, 2024
·
3 min read
Press Releases

Exact Sciences Schedules Third Quarter 2024 Earnings Call

October 8, 2024
·
1 min read
Press Releases

Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Event-Free Survival (EFS) as Perioperative Treatment Regimen in Patients With Resected, Locally Advanced Head and Neck Squamous Cell Carcinoma

October 8, 2024
·
19 min read